ResearcherShanghai Medical College of Fudan UniversityActive in the last 2 years
Jing Xie
Matched on OpenAlex author ID A5125707745. Sources: OpenAlex.
Their work
- Papers
- 3
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 9
2019: 1 paper · 2020: none · 2021: 1 paper · 2022: none · 2023: none · 2024: none · 2025: none · 2026: 1 paper
Papers 3
- Harnessing Tumor-Specific Transcript Diversity Uncovers a Shared Neoantigen Reservoir for Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.1002/mco2.70890↗
- Overexpression of Interferon-Inducible Protein 16 Promotes Progression of Human Pancreatic Adenocarcinoma Through Interleukin-1β-Induced Tumor-Associated Macro… Co-author DOI 10.3389/fcell.2021.640786↗
- Magnesium transporter protein solute carrier family 41 member 1 suppresses human pancreatic ductal adenocarcinoma through magnesium-dependent Akt/mTOR inhibiti… Co-author DOI 10.18632/aging.101940↗
Closest collaborators
The 9 strongest of 9 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Zhen Chen · 2 shared papers, 2019–2026 · strength 0.35
- Paper Harnessing Tumor-Specific Transcript Diversity Uncovers a Shared Neoantigen Reservoir for Pancreatic Ductal Adenocarcin… DOI 10.1002/mco2.70890↗
- Paper Magnesium transporter protein solute carrier family 41 member 1 suppresses human pancreatic ductal adenocarcinoma throu… DOI 10.18632/aging.101940↗
- Jingjing Zhao · 1 shared paper, 2026 · strength 0.25
- Shenglin Huang · 1 shared paper, 2026 · strength 0.25
- Wenqian Yu · 1 shared paper, 2026 · strength 0.25
- Chien‐shan Cheng · 2 shared papers, 2019–2021 · strength 0.23
- Paper Overexpression of Interferon-Inducible Protein 16 Promotes Progression of Human Pancreatic Adenocarcinoma Through Inter… DOI 10.3389/fcell.2021.640786↗
- Paper Magnesium transporter protein solute carrier family 41 member 1 suppresses human pancreatic ductal adenocarcinoma throu… DOI 10.18632/aging.101940↗
- Jingxian Chen · 1 shared paper, 2021 · strength 0.13
- Lan Zheng · 1 shared paper, 2021 · strength 0.13
- Lu-Ming Liu · 1 shared paper, 2019 · strength 0.10
- Zhi Qiang Meng · 1 shared paper, 2019 · strength 0.10
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.